203. Back to Basics - Early Pancreatic Cancer
About this episode
The episode discusses early-stage pancreatic cancer and pivotal trials related to its treatment.
This week, we take a "back to the future" look at the early-stage pancreatic cancer phase, a relatively stagnant area in terms of pivotal trials. The two trials are the ESPAC4 trial, which examines doublet chemotherapy in pancreatic cancer, and Josh does a traditional deep dive into the world of neoadjuvant chemotherapy. He highlights ESPAC-5, PREOPANC-2, and the TAPS consortium, to name a few. A complicated but overall evolving field. Studies discussed in this episode: ESPAC-4 FOLFOXIRI PREOPANC-2 ESPAC-5 TAPS (Trans-Atlantic Pancreatic Surgery (TAPS) Consortium Study) For more episodes, resources and blog posts, visit www.inquisitiveonc.com Please find us on Twitter @InquisitiveOnc! If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com Art courtesy of Taryn Silver Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/ Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice. Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time…
Sponsors
Pfizer, Merck Pharmaceuticals
More episodes of Oncology for the Inquisitive Mind
- 202. Back to Basics - Advanced Pancreatic Cancer
- 201. Back to Basics - Advanced Gastric/GOJ Cancer
- 200. Back to Basics - Early Gastric Cancer
Explore listener stats, chart rankings, contacts and more on the Oncology for the Inquisitive Mind podcast page.